Business Combinations (Tables)

9 Months Ended

Sep. 30, 2016

Pro forma Financial Information Adjusted to Give Effect to the Merger

The pro forma financial information has been adjusted to give effect to the merger as if it had occurred on January 1, 2015.

	Nine Months Ended September 30, 2015
	(in millions)
Net Sales	$	5,584.1
Net Earnings	$	248.3

Changes in Carrying Amount of Goodwill

The following table summarizes the changes in the carrying amount of our goodwill (in millions):

	Americas			EMEA			Asia Pacific			Product Category Operating Segments			Unallocated		Total
Balance at December 31, 2015
Goodwill	$	7,328.0		$	1,291.0		$	548.9		$	1,139.3		$	—	$	10,307.2
Accumulated impairment loss		—			—			—			(373.0	)		—		(373.0	)
		7,328.0			1,291.0			548.9			766.3					9,934.2
Biomet purchase accounting adjustments		(16.9	)		(10.4	)		(61.3	)		(17.6	)		—		(106.2	)
LDR purchase accounting														527.1		527.1
Other acquisitions		—			—			—			—			340.9		340.9
Currency translation		34.4			15.6			20.0			4.1			—		74.1
Balance at September 30, 2016
Goodwill		7,345.5			1,296.2			507.6			1,125.8			868.0		11,143.1
Accumulated impairment loss		—			—			—			(373.0	)		—		(373.0	)
	$	7,345.5		$	1,296.2		$	507.6		$	752.8		$	868.0	$	10,770.1

Biomet [Member]

Summary of Aggregate Preliminary Fair Values of Assets Acquired and Liabilities Assumed

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the closing date of the Biomet merger (in millions):

	Final Values
Cash	$	494.8
Accounts receivable, net		527.9
Inventory		1,224.1
Other current assets		25.4
Property, plant and equipment		775.3
Intangible assets not subject to amortization:
Trademarks and trade names		479.0
In-process research and development (IPR&D)		209.0
Intangible assets subject to amortization:
Technology		2,332.1
Customer relationships		4,961.0
Trademarks and trade names		360.0
Other assets		42.6
Goodwill		7,433.2
Total assets acquired		18,864.4
Current liabilities		584.0
Long-term debt		2,740.0
Deferred taxes		3,497.6
Other long-term liabilities		102.9
Total liabilities assumed		6,924.5
Net assets acquired	$	11,939.9

Cayenne Medical, CTC [Member]

Summary of Aggregate Preliminary Fair Values of Assets Acquired and Liabilities Assumed

The following table summarizes the aggregate preliminary estimates of fair value of the assets acquired and liabilities assumed related to the Cayenne Medical, CTC, CD Diagnostics, MedTech, and other immaterial acquisitions that occurred during the three months ended September 30, 2016 (in millions):

Current assets	$	67.9
Property, plant and equipment		4.5
Intangible assets		213.4
Goodwill		340.9
Other assets		1.1
Total assets acquired		627.8
Current liabilitites		21.5
Long-term liabilities		111.0
Total liabilities assumed		132.5
Net assets acquired	$	495.3

LDR Holding Corporation [Member]

Summary of Aggregate Preliminary Fair Values of Assets Acquired and Liabilities Assumed

The following table summarizes the preliminary estimates of fair value of the assets acquired and liabilities assumed in the LDR acquisition (in millions):

	As of July 13, 2016
Cash	$	92.8
Accounts receivable, net		31.2
Inventory		86.5
Other current assets		5.6
Property, plant and equipment		24.7
Intangible assets not subject to amortization:
In-process research and development (IPR&D)		2.0
Intangible assets subject to amortization:
Technology		431.0
Customer relationships		132.0
Trademarks and trade names		77.0
Other assets		17.4
Goodwill		527.1
Total assets acquired		1,427.3
Current liabilities		53.3
Long-term debt		0.5
Deferred taxes		259.1
Other long-term liabilities		0.5
Total liabilities assumed		313.4
Net assets acquired	$	1,113.9